The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

Expert Opin Ther Targets. 2017 Mar;21(3):231-234. doi: 10.1080/14728222.2017.1279148. Epub 2017 Jan 18.

Authors

Nicola Giuliani¹, Martina Chiu², Marina Bolzoni¹, Fabrizio Accardi¹, Massimiliano G Bianchi², Denise Toscani¹, Franco Aversa¹, Ovidio Bussolati²

Affiliations

¹ a Department of Clinical and Experimental Medicine , University of Parma , Parma , Italy.
² b Department of Biomedical , Biotechnological and Translational Sciences, University of Parma , Parma , Italy.

PMID: 28052702
DOI: 10.1080/14728222.2017.1279148

No abstract available

Keywords: ASCT2; Multiple myeloma; glutamine; metabolism; target therapy.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antineoplastic Agents / pharmacology
Biological Transport
Drug Design
Glutamine / metabolism*
Humans
Molecular Targeted Therapy*
Multiple Myeloma / drug therapy*
Multiple Myeloma / pathology

Substances

Antineoplastic Agents
Glutamine